Risk group | Lowest risk | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Highest risk | Overall |
---|---|---|---|---|---|---|---|---|---|---|---|
Patient average covariate profiles based on tenths of patient population grouped by 5-year risk of composite CVD event estimated at baseline | |||||||||||
Number of patients in dataset | 10 035 | 9903 | 9797 | 9626 | 9516 | 9455 | 9382 | 9335 | 9249 | 8668 | 94 966 |
5-year risk (%; average across patients) | 3.69 | 5.70 | 7.37 | 9.15 | 11.20 | 13.71 | 17.14 | 22.14 | 30.42 | 52.37 | 16.68 |
5-year risk (%; at average covariate values) | 3.46 | 5.43 | 6.95 | 8.53 | 10.36 | 12.57 | 15.64 | 20.07 | 27.23 | 44.18 | 11.64 |
Sociodemographic characteristics | |||||||||||
Sex (% female) | 64 | 48 | 42 | 39 | 37 | 37 | 38 | 42 | 44 | 46 | 44 |
Age (years if male) | 49 | 55 | 59 | 62 | 65 | 67 | 71 | 74 | 77 | 81 | 67 |
Age (years if female) | 53 | 62 | 67 | 70 | 73 | 75 | 78 | 80 | 83 | 87 | 72 |
Age (weighted average) | 52 | 59 | 62 | 65 | 68 | 70 | 73 | 76 | 80 | 84 | 69 |
Most deprived quintile (%) | 15 | 17 | 18 | 19 | 20 | 21 | 21 | 22 | 22 | 24 | 20 |
Stable-CAD diagnosis (%) | |||||||||||
NSTEMI | 0 | 1 | 3 | 5 | 8 | 10 | 12 | 17 | 23 | 43 | 10 |
STEMI | 1 | 4 | 8 | 12 | 13 | 14 | 13 | 9 | 6 | 4 | 7 |
Unstable angina | 10 | 13 | 12 | 12 | 12 | 12 | 13 | 15 | 17 | 15 | 14 |
Stable angina | 78 | 65 | 56 | 49 | 43 | 39 | 37 | 34 | 29 | 18 | 47 |
Non-specific CHD | 11 | 17 | 20 | 22 | 24 | 24 | 25 | 26 | 25 | 20 | 23 |
Stable-CAD severity (%) | |||||||||||
PCI in past 6 months | 9 | 12 | 13 | 14 | 13 | 13 | 11 | 9 | 6 | 4 | 9 |
CABG in past 6 months | 9 | 7 | 6 | 5 | 5 | 4 | 4 | 3 | 2 | 1 | 4 |
Previous/recurrent MI | 2 | 6 | 10 | 14 | 18 | 23 | 26 | 29 | 32 | 43 | 18 |
Use of nitrates | 10 | 16 | 19 | 21 | 24 | 28 | 33 | 37 | 43 | 56 | 28 |
CVD risk factors | |||||||||||
Smoking status (%) | |||||||||||
Current smoker | 31 | 35 | 36 | 37 | 38 | 38 | 37 | 35 | 32 | 30 | 35 |
Ex-smoker | 27 | 30 | 31 | 32 | 32 | 33 | 34 | 34 | 34 | 34 | 32 |
Never smoked | 41 | 35 | 33 | 31 | 30 | 29 | 29 | 31 | 33 | 36 | 33 |
Hypertension (%) | 69 | 70 | 71 | 71 | 72 | 74 | 76 | 79 | 83 | 87 | 76 |
Diabetes (%) | 4 | 8 | 10 | 12 | 14 | 16 | 18 | 21 | 24 | 32 | 16 |
Total cholesterol (mmol/L) | 4.95 | 4.91 | 4.84 | 4.79 | 4.74 | 4.74 | 4.70 | 4.68 | 4.64 | 4.54 | 4.79 |
HDL (mmol/L) | 1.41 | 1.37 | 1.35 | 1.35 | 1.35 | 1.35 | 1.36 | 1.37 | 1.37 | 1.35 | 1.37 |
CVD comorbidities (%) | |||||||||||
Heart failure | 5 | 7 | 9 | 12 | 15 | 19 | 27 | 37 | 52 | 73 | 26 |
Peripheral arterial disease | 1 | 2 | 3 | 4 | 6 | 8 | 10 | 13 | 16 | 25 | 8 |
Atrial fibrillation | 3 | 5 | 7 | 9 | 10 | 13 | 16 | 21 | 29 | 43 | 15 |
Stroke | 0 | 1 | 1 | 2 | 3 | 5 | 8 | 14 | 22 | 39 | 9 |
Non-CVD comorbidities (%) | |||||||||||
Chronic kidney disease | 2 | 2 | 3 | 4 | 4 | 5 | 7 | 9 | 12 | 20 | 7 |
Chronic obstructive pulmonary disease | 20 | 20 | 20 | 21 | 22 | 23 | 25 | 27 | 28 | 30 | 23 |
Cancer | 4 | 5 | 6 | 7 | 8 | 9 | 11 | 13 | 14 | 12 | 9 |
Chronic liver disease | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Psychosocial characteristics | |||||||||||
Depression at diagnosis (%) | 20 | 17 | 15 | 15 | 14 | 14 | 15 | 17 | 18 | 21 | 17 |
Anxiety at diagnosis (%) | 7 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 10 | 12 | 8 |
Biomarkers | |||||||||||
Heart rate (bpm) | 72 | 71 | 71 | 71 | 71 | 71 | 72 | 73 | 74 | 76 | 72 |
Creatinine (mmol/L) | 88 | 92 | 95 | 96 | 98 | 100 | 101 | 104 | 109 | 125 | 100 |
White cell count (109/L) | 6.81 | 7.05 | 7.19 | 7.31 | 7.44 | 7.54 | 7.62 | 7.76 | 7.88 | 8.22 | 7.46 |
Haemoglobin (g/100 mL) | 1.43 | 1.43 | 1.42 | 1.41 | 1.39 | 1.37 | 1.35 | 1.32 | 1.28 | 1.22 | 1.36 |
Deprivation measured by index of multiple deprivation, 2010. All values in table are means. Percentage of missing data imputed: smoking status 32%, total cholesterol 54%, HDL 55%, heart rate 78%, creatinine 38%, white cell count 56% and haemoglobin 53%.
CABG, coronary artery bypass graft; CAD, coronary artery disease; CHD, coronary heart disease; CVD, cardiovascular disease; HDL, high-density lipoprotein; MI, myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; stable-CAD, stable coronary artery disease; STEMI, ST segment elevation myocardial infarction.